| The microRNA spectrum in 12 body fluids | Clinical Chemistry | 2010 | 1.9K |
| Silver nanoparticle applications and human health | Clinica Chimica Acta | 2010 | 914 |
| Analytical validation of a high-sensitivity cardiac troponin T assay | Clinical Chemistry | 2010 | 791 |
| A catalogue of reporting guidelines for health research | European Journal of Clinical Investigation | 2010 | 762 |
| Metals, oxidative stress and neurodegenerative disorders | Molecular and Cellular Biochemistry | 2010 | 745 |
| Glutamate receptors, neurotoxicity and neurodegeneration | Pflugers Archiv European Journal of Physiology | 2010 | 744 |
| Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles | Metabolomics | 2010 | 621 |
| Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure | Clinical Biochemistry | 2010 | 616 |
| Recent developments in PDMS surface modification for microfluidic devices | Electrophoresis | 2010 | 594 |
| Nitric oxide and oxidative stress in vascular disease | Pflugers Archiv European Journal of Physiology | 2010 | 494 |
| VDAC, a multi-functional mitochondrial protein regulating cell life and death | Molecular Aspects of Medicine | 2010 | 481 |
| Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria | Antioxidants and Redox Signaling | 2010 | 471 |
| Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules | Biomedical Chromatography | 2010 | 458 |
| Basic biochemical mechanisms behind the health benefits of polyphenols | Molecular Aspects of Medicine | 2010 | 453 |
| When NRF2 talks, who's listening? | Antioxidants and Redox Signaling | 2010 | 451 |
| Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities | Antioxidants and Redox Signaling | 2010 | 443 |
| MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) | Clinica Chimica Acta | 2010 | 441 |
| Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders | Antioxidants and Redox Signaling | 2010 | 434 |
| The origin of fibroblasts and mechanism of cardiac fibrosis | Journal of Cellular Physiology | 2010 | 428 |
| Halogen atoms in the modern medicinal chemistry: hints for the drug design | Current Drug Targets | 2010 | 422 |
| Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway | Antioxidants and Redox Signaling | 2010 | 413 |
| NF-kappaB signaling: multiple angles to target OA | Current Drug Targets | 2010 | 407 |
| Biochemical markers of muscular damage | Clinical Chemistry and Laboratory Medicine | 2010 | 399 |
| Fluorescent protein-based redox probes | Antioxidants and Redox Signaling | 2010 | 398 |
| The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum | Clinical Chemistry | 2010 | 395 |
